$67.79
-3.44-4.83%
Last update: Nov 10, 4:25 PM
National Health Investors Inc
NHINYSE
The average analyst price target for National Health Investors is $77, 14.9% above the current price. Of 8 analysts, 6 rate it Buy and 2 Hold. Targets range from $55 to $94. The latest change came on Oct 19, 2026, when Wells Fargo lowered its price target on National Health Investors from $78 to $68 and kept an Equal-Weight rating.
Price Target Range — 13 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
